1.
Kiyani M, Clanahan O, Silverman MA. Heterogeneity in Infection Reporting Across Covalent Bruton Tyrosine Kinase Inhibitor Studies in B-Cell Malignancies: A Systematic Review. J Hematol [Internet]. 2026 Jan. 1 [cited 2026 Nov. 4];15(5):219-24. Available from: https://jh.elmerpub.com/jh/article/view/2233